Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: A report from the Children's Cancer Group

Blood

Volumn 90, Issue 1, 1997, Pages 28-35

  Uckun, Fatih M ^a   Sather, Harland N ^b   Gaynon, Paul S ^b   Arthur, Diane C ^b   Trigg, Michael E ^b   Tubergen, David G ^b   Nachman, James ^b   Steinherz, Peter G ^b   Sensel, Martha G ^b   Reaman, Gregory H ^b  

^a PARKER HUGHES INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIGEN DETECTION; ARTICLE; CANCER SURVIVAL; CANCER THERAPY; CHILD; FEMALE; HUMAN; IMMUNOPHENOTYPING; INFANT; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

ADOLESCENT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0030997662     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Pullen DJ, Boyett JM, Crist WM, Falletta JM, Roper M, Dowell B, Van Eys J, Jackson JF, Humphrey GB, Metzgar RS, Cooper MD: Pediatric oncology group utilization of immunologic markers in the designation of acute lymphocytic leukemia subgroups: Influence on treatment response. Ann NY Acad Sci 428:26, 1984
2. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, vant Veer MB: Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9:1783, 1995
3. Pui CH, Behm FG, Crist WM: Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 82:343, 1993
4. Sallan SE, Ritz J, Pesando J, Gelber R, O'Brien C, Hitchcock S, Coral F, Schlossman SF: Cell surface antigens: Prognostic implications in childhood acute lymphoblastic leukemia. Blood 55:395, 1980
5. Kurec AS, Belair P, Stefanu C, Barrett DM, Dubowy RL, Davey FR: Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia. Cancer 67:3081, 1991
6. Ludwig WD, Bartram CR, Ritter J, Raghavachar A, Hiddemann W, Heil G, Harbott J, Seibt Jung H, Teichmann JV, Riehm H: Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis. Blood 71:1518, 1988
7. Champlin R, Gale RP: Acute lymphoblastic leukemia: Recent advances in biology and therapy [see comments]. Blood 73:2051, 1989
8. Greaves MF: Differentiation-linked leukemogenesis in lymphocytes. Science 234:697, 1986
9. Reinherz EL, Kung PC, Goldstein G, Levey RH, Schlossman SF: Discrete stages of human intrathymic differentiation: Analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci USA 77:1588, 1980
10. Ludwig WD, Teichmann JV, Sperling C, Komischke B, Ritter J, Reiter A, Odenwald E, Sauter S, Riehm H: Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: Experiences of the ALL-BFM 83 and 86 studies. Klin Padiatr 202:243, 1990
11. Ludwig WD, Harbott J, Bartram CR, Komischke B, Sperling C, Teichmann JV, Seibt Jung H, Notter M, Odenwald E, Nehmer A, Thiel E, Riehm H: Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: Experience of the BFM study 86. Recent Results Cancer Res 131:269, 1993
12. Ludwig WD, Reiter A, Loffler H, Gokbuget, Hoelzer D, Riehm H, Thiel E: Immunophenotypic features of childhood and adult acute lymphoblastic leukemia (ALL): Experience of the German Multicentre Trials ALL-BFM and GMALL. Leuk Lymphoma 1:71, 1994 (suppl 1)
13. Bradstock KF, Kirk J, Grimsley PG, Kabral A, Hughes WG: Unusual immunophenotypes in acute leukaemias: Incidence and clinical correlations. Br J Haematol 72:512, 1989
14. Cantu Rajnoldi A, Putti C, Saitta M, Granchi D, Foa R, Schiro R, Castagni M, Valeggio C, Jankovic M, Miniero R, Paulucci P, Basso G: Co-expression of myeloid antigens in childhood acute lymphoblastic leukaemia: Relationship with the stage of differentiation and clinical significance [see comments]. Br J Haematol 79:40, 1991
15. Fink FM, Koller U, Mayer H, Haas OA, Grumayer Panzer ER, Urban C, Dengg K, Mutz I, Tuchler H, Gatterer Menz I, Knapp W, Gadner H: Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia. The Austrian Pediatric Oncology Group. Med Pediatr Oncol 21:340, 1993
16. Hsu PN, Tien HF, Wang CH, Chen YC, Shen MC, Lin DT, Lin KH, Liang DC, Lin KS: A subset of acute lymphoblastic leukemia with coexpression of myeloid antigens: Prevalence and clinical significance. J Formosan Med Assoc 90:225, 1991
17. Pui CH, Behm FG, Singh B, Rivera GK, Schell MJ, Roberts WM, Crist WM, Mirro J Jr: Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 75:198, 1990
18. Pui CH, Raimondi SC, Head DR, Schell MJ, Rivera GK, Mirro J Jr, Crist WM, Behm FG: Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse [see comments]. Blood 78:1327, 1991
19. Urbano Ispizua A, Matutes E, Villamor N, Ribera JM, Feliu E, Montserrat E, Granena A, Vives Corrons JL, Rozman C: Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia. Br J Haematol 75:202, 1990
20. Wiersma SR, Ortega J, Sobel E, Weinberg KI: Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood [see comments]. N Engl J Med 324:800, 1991
21. Greaves MF, Chan LC, Furley AJ, Watt SM, Molgaard HV: Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 67:1, 1986
22. Smith LJ, Curtis JE, Messner HA, Senn JS, Furthmayr H, McCulloch EA: Lineage infidelity in acute leukemia. Blood 61:1138, 1983
23. McCulloch EA, Smith LJ, Alder S: Cellular lineages in normal and leukemic hemopoiesis. Prog Clin Biol Res 134:229, 1983
24. Mirro J, Zipf TF, Pui CH, Kitchingman G, Williams D, Melvin S, Murphy SB, Stass S: Acute mixed lineage leukemia: Clinicopathologic correlations and prognostic significance. Blood 66:1115, 1985
25. Steinherz PG, Siegel SE, Bleyer WA, Kersey J, Chard R Jr, Coccia P, Leiken S, Lukens J, Neerhout R, Nesbit M, Miller DR, Reaman G, Sather H, Hammond D: Lymphomatous presentation of childhood acute lymphoblastic leukemia. Cancer 68:751, 1991
26. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R: Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia [see comments]. J Clin Oncol 14:18, 1996
27. Uckun FM, Ledbetter JA: Immunobiologic differences between normal and leukemic human B-cell precursors. Proc Natl Acad Sci USA 85:8603, 1988
28. Uckun FM, Muraguchi A, Ledbetter JA, Kishimoto T, O'Brien RT, Roloff JS, Gajl Peczalska K, Provisor A, Koller B: Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood 73:1000, 1989
29. Hollander M, Wolfe D: Nonparametric Statistical Methods. New York, NY, Wiley, 1973
30. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
31. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163, 1966
32. Peto R, Pike MC, Armitage P, Breslow N, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II. Analysis and examples. Br J Cancer 35:1, 1977
33. Breslow N: Comparison of survival curves, in Buyse M, Staquet M, Sylvester M (eds): Cancer Clinical Trials: Methods and Practice. Oxford, UK, Oxford, 1988, p 381
34. Breslow N: Analysis of survival data under the proportional hazards model. Int Stat Rev 43:45, 1975
35. Drexler HG, Ludwig WD: Incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Recent Results Cancer Res 131:53, 1993
36. Borowitz MJ, Shuster JJ, Civin CI, Carroll AJ, Look AT, Behm FG, Land VJ, Pullen DJ, Crist WM: Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: A Pediatric Oncology Group study. J Clin Oncol 8:1389, 1990
37. Guyotat D, Campos L, Shi ZH, Charrin C, Treille D, Magaud JP, Fiere D: Myeloid surface antigen expression in adult acute lymphoblastic leukemia. Leukemia 4:664, 1990
38. Saeland S, Duvert V, Caux C, Pandrau D, Favre C, Valle A, Durand I, Charbord P, de Vries J, Banchereau J: Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells. Exp Hematol 20:24, 1992
39. Greaves MF, Brown J, Molgaard HV, Spurr NK, Robertson D, Delia D, Sutherland DR: Molecular features of CD34: A hemopoietic progenitor cell-associated molecule. Leukemia 1:31, 1992 (suppl 6)
40. Simmons DL, Satterthwaite AB, Tenen DG, Seed B: Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. J Immunol 148:267, 1992
41. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S: The CD40 antigen and its ligand. Annu Rev Immunol 12:881, 1994
42. Stamenkovic I, Clark EA, Seed B: A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8:1403, 1989
43. Ledbetter JA, Shu G, Gallagher M, Clark EA: Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen Bp50 (Cdw40). J Immunol 138:788, 1987
44. Uckun FM, Gajl Peczalska K, Myers DE, Jaszcz W, Haissig S, Ledbetter JA: Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood 76:2449, 1990
45. Kaspers GJ, Kardos G, Pieters R, Van Zantwijk CH, Klumper E, Hahlen K, de Waal FC, van Wering ER, Veerman AJ: Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: A preliminary report. Leukemia 8:1224, 1994
46. Pui C, Schell M, Raimondi S, Head D, Rivera G, Crist W, Behm F: Myeloid antigen expression in childhood acute lymphoblastic leukemia. N Engl J Med 325:1378, 1991 (letter)